SE429966B - Di-0-n-alkylglycerolderivat med immunitetsstimulerande verkan och farmaceutiska beredningar innehallande detta - Google Patents

Di-0-n-alkylglycerolderivat med immunitetsstimulerande verkan och farmaceutiska beredningar innehallande detta

Info

Publication number
SE429966B
SE429966B SE7904216A SE7904216A SE429966B SE 429966 B SE429966 B SE 429966B SE 7904216 A SE7904216 A SE 7904216A SE 7904216 A SE7904216 A SE 7904216A SE 429966 B SE429966 B SE 429966B
Authority
SE
Sweden
Prior art keywords
alkyl
general formula
compounds
carbon atoms
pharmaceutically acceptable
Prior art date
Application number
SE7904216A
Other languages
English (en)
Swedish (sv)
Other versions
SE7904216L (sv
Inventor
A R Kraska
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7904216L publication Critical patent/SE7904216L/xx
Publication of SE429966B publication Critical patent/SE429966B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/44Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reduction and hydrolysis of nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE7904216A 1978-05-15 1979-05-14 Di-0-n-alkylglycerolderivat med immunitetsstimulerande verkan och farmaceutiska beredningar innehallande detta SE429966B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/906,260 US4173641A (en) 1978-05-15 1978-05-15 Di-O-n-alkyl glycerol derivatives as immune stimulants

Publications (2)

Publication Number Publication Date
SE7904216L SE7904216L (sv) 1979-11-16
SE429966B true SE429966B (sv) 1983-10-10

Family

ID=25422164

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7904216A SE429966B (sv) 1978-05-15 1979-05-14 Di-0-n-alkylglycerolderivat med immunitetsstimulerande verkan och farmaceutiska beredningar innehallande detta

Country Status (38)

Country Link
US (1) US4173641A (no)
JP (2) JPS5924974B2 (no)
AR (1) AR221724A1 (no)
AT (1) AT372678B (no)
AU (1) AU513771B2 (no)
BE (1) BE876229A (no)
CA (1) CA1105935A (no)
CH (1) CH639939A5 (no)
DD (1) DD144540A5 (no)
DE (1) DE2919514C2 (no)
DK (1) DK149946C (no)
EG (1) EG15252A (no)
ES (1) ES480565A1 (no)
FI (1) FI69450C (no)
FR (1) FR2426039A1 (no)
GB (1) GB2021580B (no)
GR (1) GR72419B (no)
GT (1) GT197957869A (no)
HK (1) HK13584A (no)
HU (1) HU180283B (no)
IE (1) IE48229B1 (no)
IL (1) IL57268A (no)
IN (1) IN150574B (no)
IT (1) IT1115217B (no)
KE (1) KE3354A (no)
LU (1) LU81253A1 (no)
MY (1) MY8500096A (no)
NL (1) NL175524C (no)
NO (1) NO151285C (no)
NZ (1) NZ190444A (no)
PH (1) PH15256A (no)
PL (1) PL123910B1 (no)
PT (1) PT69607A (no)
SE (1) SE429966B (no)
SG (1) SG65483G (no)
SU (1) SU1122220A3 (no)
YU (1) YU41156B (no)
ZA (1) ZA792306B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255426A (en) * 1979-07-09 1981-03-10 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted-piperazines and piperidines
US4312877A (en) * 1979-07-09 1982-01-26 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted piperidines, pharmaceutical compositions, thereof and use thereof
US4310550A (en) * 1979-10-26 1982-01-12 Pfizer Inc. Lipid amines formulated with fat or lipid emulsions as vaccine adjuvants
US4395394A (en) * 1979-10-26 1983-07-26 Pfizer Inc. Use of lipid amines formulated with fat or lipid emulsions as vaccine adjuvants
JPS60105650A (ja) * 1983-11-14 1985-06-11 Ono Pharmaceut Co Ltd グリセリン誘導体、その製造方法及びその誘導体を含有する薬剤
US4880626A (en) * 1985-01-18 1989-11-14 Mcmichael John Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome
JPS62156230A (ja) * 1985-12-27 1987-07-11 Nippon Steel Corp 帯状物の蛇行修正方法
US4842862A (en) * 1986-07-03 1989-06-27 International Minerals & Chemical Corp. Immunostimulating agents
ZA899436B (en) * 1988-12-12 1990-08-29 Ciba Geigy Piperidine derivatives
WO2005077963A1 (fr) * 2004-01-16 2005-08-25 Institut Superieur Agricole De Beauvais DErivEs de saccharides et d'itols possEdant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme mEdicaments dans les pathologies prolifEratives tumorales ou bEnignes.
SG10201407996PA (en) 2009-12-23 2015-01-29 Novartis Ag Lipids, lipid compositions, and methods of using them

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738351A (en) * 1952-08-02 1956-03-13 Bristol Lab Inc Substituted glycerol ethers
US3432602A (en) * 1967-12-20 1969-03-11 Astra Ab Oral alkyl glycerol ether improvement in radiation,radiomimetic,or cytostatic tumor therapies
US3943173A (en) * 1972-11-22 1976-03-09 Smithkline Corporation 3-Alkylamino- alpha-aminomethyl-4-hydroxybenzyl alcohols
US4012528A (en) * 1974-06-03 1977-03-15 Smithkline Corporation α-AMINOALKYL-3-(1,2-DIHYDROXYETHYL)-4-HYDROXY-BENZYL ALCOHOLS HAVING β-ADRENERGIC STIMULANT ACTIVITY
US4069223A (en) * 1977-05-02 1978-01-17 G. D. Searle & Co. 4-Aminomethyl-1-(3,3,3-triarylpropyl)-4-arylpiperidine and derivatives thereof
US4166132A (en) * 1977-08-18 1979-08-28 Pfizer Inc. Antiviral amine derivatives of glycerol and propanediols

Also Published As

Publication number Publication date
IL57268A0 (en) 1979-09-30
IT1115217B (it) 1986-02-03
AU513771B2 (en) 1980-12-18
YU41156B (en) 1986-12-31
NL175524C (nl) 1984-11-16
NO151285C (no) 1985-03-13
IT7922664A0 (it) 1979-05-14
DK102479A (da) 1979-11-16
HU180283B (en) 1983-02-28
ZA792306B (en) 1980-05-28
IL57268A (en) 1982-05-31
IE48229B1 (en) 1984-11-14
AT372678B (de) 1983-11-10
DD144540A5 (de) 1980-10-22
EG15252A (en) 1986-09-30
JPS5924974B2 (ja) 1984-06-13
NO151285B (no) 1984-12-03
ES480565A1 (es) 1980-08-16
SE7904216L (sv) 1979-11-16
GR72419B (no) 1983-11-03
DE2919514A1 (de) 1979-11-22
NZ190444A (en) 1981-05-29
MY8500096A (en) 1985-12-31
GB2021580A (en) 1979-12-05
JPS6139301B2 (no) 1986-09-03
CA1105935A (en) 1981-07-28
AR221724A1 (es) 1981-03-13
GB2021580B (en) 1982-09-08
FI69450B (fi) 1985-10-31
HK13584A (en) 1984-02-24
KE3354A (en) 1983-12-16
FR2426039B1 (no) 1983-12-16
YU109479A (en) 1983-02-28
NO791604L (no) 1979-11-16
CH639939A5 (fr) 1983-12-15
FI791531A (fi) 1979-11-16
GT197957869A (es) 1980-11-04
AU4701679A (en) 1979-11-22
NL7903769A (nl) 1979-11-19
ATA356179A (de) 1983-03-15
PL215573A1 (no) 1980-07-01
SU1122220A3 (ru) 1984-10-30
PT69607A (en) 1979-06-01
PL123910B1 (en) 1982-12-31
IE790938L (en) 1979-11-15
DK149946C (da) 1987-06-15
DK149946B (da) 1986-11-03
IN150574B (no) 1982-11-13
JPS58131947A (ja) 1983-08-06
SG65483G (en) 1984-07-27
US4173641A (en) 1979-11-06
DE2919514C2 (de) 1982-06-03
FI69450C (fi) 1986-02-10
FR2426039A1 (fr) 1979-12-14
LU81253A1 (fr) 1979-12-07
BE876229A (fr) 1979-11-14
PH15256A (en) 1982-11-02
JPS55378A (en) 1980-01-05

Similar Documents

Publication Publication Date Title
CA1102354A (en) Antiviral amine derivatives of glycerol
SE429966B (sv) Di-0-n-alkylglycerolderivat med immunitetsstimulerande verkan och farmaceutiska beredningar innehallande detta
CA1159827A (en) Esters
EP0399504B1 (en) Aryloxyphenylpropylamines their preparation and use
US3013020A (en) N,n'-bis-phenyl-alkylene-diamines
DK165405B (da) Aryloxyphenylpropylaminer og deres farmaceutisk acceptable salte, deres fremstilling samt farmaceutiske praeparater indeholdende disse forbindelser
PT86919B (pt) Metodo para a utilizacao de derivados de morfolina em medicina e agricultura e respectivo processo de preparacao
CA1195328A (en) Phenoxypropanolamine derivatives
US2628973A (en) Aryloxyacetates of basically substituted arylakanols and derivatives thereof
FI75802B (fi) Foerfarande foer framstaellning av saosom immunostimulerande aemnen anvaendbara bis- och polydisulfider.
JPS6217589B2 (no)
US4318925A (en) 4-Homoisotwistane derivatives
Curtis 6-Methoxymellein as a phytoalexin
US3929766A (en) Novel 2{8 2-(1,3-diazacycloalk-2-enyl){9 benzophenone derivatives and novel 1,3-diazacycloalkenyl{8 2,1-A{9 isoindole derivatives
KR830000771B1 (ko) 디-0-n-알킬 글리세롤 유도체의 제조방법
JPH0667880B2 (ja) gem−ジハロ−1,8−ジアミノ−4−アザ−オクタン類
US4215146A (en) Antiviral amine derivatives of glycerol and propanediols
EP0034002A2 (en) Carboxamidine derivatives
US3121724A (en) Aminoalkyl ethers of 6-halobenzyl-5-indanol and 7-halobenzyl-4-indanol
EP0022371B1 (en) Substituted piperazines and piperidines and pharmaceutical compositions containing them
DK157994B (da) Analogifremgangsmaade til fremstilling af en terapeutisk aktiv alkanolaminforbindelse
JPS5931492B2 (ja) 2−(オメガ−アミノアルコキシ)ジフエニルメチルメタン類
JPS6048507B2 (ja) 2―(ω―アミノアルコキシ)ジフエニルスルフイド類
Lu POTENTIAL AGENTS FOR CHAGAS'DISEASE.
JPS62277371A (ja) 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7904216-4

Effective date: 19931210

Format of ref document f/p: F